These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15295679)

  • 41. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic therapy for age-related macular degeneration: a candid appraisal.
    Sternberg P; Lewis H
    Am J Ophthalmol; 2004 Mar; 137(3):483-5. PubMed ID: 15013872
    [No Abstract]   [Full Text] [Related]  

  • 43. Photodynamic therapy for age-related macular degeneration.
    Beck RW
    Am J Ophthalmol; 2004 Sep; 138(3):513; author reply 513-4. PubMed ID: 15364257
    [No Abstract]   [Full Text] [Related]  

  • 44. Back pain after photodynamic therapy with verteporfin.
    Pece A; Vadalà M; Manzi R; Calori G
    Am J Ophthalmol; 2006 Mar; 141(3):593-4. PubMed ID: 16490525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
    Chaudhry NA; Lavaque AJ; Shah A; Liggett PE
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):70-2. PubMed ID: 15688974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute severe vision decrease immediately after photodynamic therapy.
    Beaumont P; Lim CS; Chang A; Kang K
    Arch Ophthalmol; 2004 Oct; 122(10):1546-7. PubMed ID: 15477472
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complications after photodynamic therapy.
    Schnurrbusch UE; Jochmann C; Einbock W; Wolf S
    Arch Ophthalmol; 2005 Oct; 123(10):1347-50. PubMed ID: 16219725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.
    Chaudhary V; Mao A; Hooper PL; Sheidow TG
    Ophthalmology; 2007 Dec; 114(12):2183-9. PubMed ID: 18054638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
    Arnold JJ; Blinder KJ; Bressler NM; Bressler SB; Burdan A; Haynes L; Lim JI; Miller JW; Potter MJ; Reaves A; Rosenfeld PJ; Sickenberg M; Slakter JS; Soubrane G; Strong HA; Stur M; ;
    Am J Ophthalmol; 2004 Apr; 137(4):683-96. PubMed ID: 15059708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns.
    Axer-Siegel R; Ehrlich R; Yassur Y; Rosenblatt I; Kramer M; Priel E; Benjamini Y; Weinberger D
    Am J Ophthalmol; 2004 Feb; 137(2):258-64. PubMed ID: 14962414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transient visual disturbance after photodynamic therapy.
    Mennel S; Meyer CH
    Am J Ophthalmol; 2005 Apr; 139(4):748-9; author reply 749. PubMed ID: 15808191
    [No Abstract]   [Full Text] [Related]  

  • 57. Macular hole following photodynamic therapy.
    Mansour AM; Husseini ZM; Schakal AR
    Ophthalmic Surg Lasers; 2002; 33(6):511-3. PubMed ID: 12449231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute severe visual decrease after photodynamic therapy with verteporfin: spectral-domain OCT features.
    Keane PA; Aghaian E; Ouyang Y; Chong LP; Sadda SR
    Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S85-8. PubMed ID: 21117609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bilateral punctal-canalicular stenosis following photodynamic therapy for choroidal neovascularization.
    Yim JF; Crofts KP
    Cutan Ocul Toxicol; 2011 Mar; 30(1):78-9. PubMed ID: 20950246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Massive subretinal hemorrhage after photodynamic therapy for polypoidal choroidal vasculopathy after macular translocation surgery.
    Fukushima Y; Gomi F; Ohji M; Tano Y
    Jpn J Ophthalmol; 2007; 51(4):307-9. PubMed ID: 17660996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.